Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, Lapp CW, Peterson DL; Chronic Fatigue Syndrome AMP-516 Study Group, Mitchell WM.

PLoS One. 2012;7(3):e31334. doi: 10.1371/journal.pone.0031334. Epub 2012 Mar 14.

PMID:
22431963
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Q fever in an American tourist returned from Australia.

Cohen NJ, Papernik M, Singleton J, Segreti J, Eremeeva ME.

Travel Med Infect Dis. 2007 May;5(3):194-5. Epub 2006 Oct 16.

PMID:
17448948
[PubMed - indexed for MEDLINE]
3.

Estimating the prevalence of chronic fatigue syndrome among nurses.

Jason LA, Wagner L, Rosenthal S, Goodlatte J, Lipkin D, Papernik M, Plioplys S, Plioplys AV.

Am J Med. 1998 Sep 28;105(3A):91S-93S.

PMID:
9790488
[PubMed - indexed for MEDLINE]
4.

Zafirlukast and Churg-Strauss syndrome.

Katz RS, Papernik M.

JAMA. 1998 Jun 24;279(24):1949; author reply 1950. No abstract available.

PMID:
9643848
[PubMed - indexed for MEDLINE]
5.

Chronic fatigue.

Lipkin DM, Papernik M, Kaan R.

Am J Psychiatry. 1997 Sep;154(9):1322. No abstract available.

PMID:
9286207
[PubMed - indexed for MEDLINE]
6.

Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study.

Jason LA, Taylor R, Wagner L, Holden J, Ferrari JR, Plioplys AV, Plioplys S, Lipkin D, Papernik M.

Am J Community Psychol. 1995 Aug;23(4):557-68.

PMID:
8546110
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk